The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 130.00
Ask: 145.00
Change: -2.50 (-1.79%)
Spread: 15.00 (11.538%)
Open: 142.50
High: 142.50
Low: 137.50
Prev. Close: 140.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

26 Jan 2021 14:47

RNS Number : 9573M
Manolete Partners PLC
26 January 2021
 

26 January 2021

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014 ("MAR").

Manolete Partners Plc

("Manolete" or the "Company")

Q3 Trading Update

 

Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK, announces record case completions and record completed case cash inflows but a continued low level of new case investments caused by the ongoing extraordinary UK Government economic support measures. All numbers in this document are unaudited and from internal Company sources.

As highlighted in the Company's interim results for the six months ended 30 September 2020 (announced 10 November 2020), new case enquiries had begun to slow sharply due to the extraordinary UK Government economic support measures that have directly led to a large decrease in the number of UK company insolvencies since the start of the Covid-19 pandemic. This has continued throughout Q3 and into the first few weeks of Q4. The Government measures are planned to continue through to April 2021 at least and so we expect the negative impact on the Company's level of new cases (which continue to be subject to our stringent levels of selection criteria) to persist for the remainder of the current financial year ending 31 March 2021.

In the third quarter of the Company's current financial year ending 31 March 2021, Manolete completed a further 43 insolvency litigation claims bringing the total for the nine months to 31 December 2020 to 95 completed cases. At the time of writing this has now risen to 108 completed cases. This is 100% higher than the 54 cases completions for the whole 12 months of the previous year ended 31 March 2020.

The 95 completed cases for the nine months to 31 December 2020 generated a gross total settlement value of [1]£23.9m, comfortably exceeding board expectations.

Gross cash collected from completed cases in the first nine months to 31 December 2020 increased by 60% to a record £9.3m (nine months ended 31 December 2019: £5.8m). After payments to Insolvent Estates and legal fees, the Company's retained share of this cash increased by 60% to £4.8m (nine months ended 31 December 2019: £3.0m). Cash overheads for the nine-month period were £3.2m (prior year nine-month period: £3.0m), resulting in a cash inflow after payment of operational overheads of £1.5m, compared to an outflow of £32k for the comparable prior year nine-month period. Gross cash generation in Q3 of £5.1m was particularly strong with cash generated from completed cases covering not only all completed case costs and all overheads but also all costs of around 250 ongoing live cases which are expected to generate very significant cash in the Company's normal timeframes.

As a consequence of the above factors, the Board expects realised profits to be above, but unrealised profits to be significantly below, market expectations and therefore for the Company to be overall marginally EBIT profitable in H2.

Longer term, the Board believes that as the UK Government economic support measures are phased out, the longer-term impact of COVID-19 on the UK economy will lead to an increased rate of corporate insolvencies, and will underpin the Company's strong growth prospects for the foreseeable future. The Board will continue to closely monitor the evolving situation and the impact on anticipated levels of litigation finance enquiries in and beyond the near term, and the naturally needed conservatism to be applied to fair values of ongoing cases.

Steven Cooklin, CEO of Manolete, commented: "As we highlighted in our recent interim results, the emergency UK Government actions in response to the pandemic have led to a dramatic decrease in the number of UK insolvencies. This has led to a distorted reality for the economy - many commentators, including last week the Federation for Small Businesses, have highlighted the very high levels of UK companies in significant financial distress. As a consequence, we have a temporary distortion in our new cases and therefore bottom-line profits, though an excellent performance in terms of case completions and strong cash generation. Longer term, the impact of Covid-19 and its consequences on the global economy, is likely to underpin Manolete's strong growth prospects for the foreseeable future".

 

For further information, please contact:

 

Manolete Partners Plc via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

 

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

James Britton

Rishi Shah

Duncan Littlejohns

 

Instinctif Partners (Financial PR)

Tim Linacre +44 (0)7949 939237

 


[1] Includes one case with a discounted revenue of £9.3m as disclosed in the Interim results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZQLFLFFLZBBQ
Date   Source Headline
8th May 20247:00 amRNSAppointment of New External Audit Firm
2nd May 20247:00 amRNSChange of Auditor
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 202111:03 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.